These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15208211)

  • 1. HIV Env reduction postreceptor binding: a new target for AIDS treatment?
    Fenouillet E; Barbouche R; Jones IM
    Blood; 2004 Jul; 104(1):296. PubMed ID: 15208211
    [No Abstract]   [Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion.
    Abrahamyan LG; Markosyan RM; Moore JP; Cohen FS; Melikyan GB
    J Virol; 2003 May; 77(10):5829-36. PubMed ID: 12719576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV entry and tropism: the chemokine receptor connection.
    Berger EA
    AIDS; 1997; 11 Suppl A():S3-16. PubMed ID: 9451961
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
    Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
    Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion.
    Barbouche R; Miquelis R; Jones IM; Fenouillet E
    J Biol Chem; 2003 Jan; 278(5):3131-6. PubMed ID: 12218052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry.
    Markovic I; Stantchev TS; Fields KH; Tiffany LJ; Tomiç M; Weiss CD; Broder CC; Strebel K; Clouse KA
    Blood; 2004 Mar; 103(5):1586-94. PubMed ID: 14592831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-cell fusion assay to study role of chemokine receptors in human immunodeficiency virus type 1 entry.
    Rucker J; Doranz BJ; Edinger AL; Long D; Berson JF; Doms RW
    Methods Enzymol; 1997; 288():118-33. PubMed ID: 9356991
    [No Abstract]   [Full Text] [Related]  

  • 8. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.
    Rawat SS; Gallo SA; Eaton J; Martin TD; Ablan S; KewalRamani VN; Wang JM; Blumenthal R; Puri A
    J Virol; 2004 Jul; 78(14):7360-8. PubMed ID: 15220409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
    Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
    Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1.
    Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS
    J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection.
    Doms RW
    Virology; 2000 Oct; 276(2):229-37. PubMed ID: 11040114
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
    Matsuda S; Miyata M
    Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses.
    Willett BJ; Picard L; Hosie MJ; Turner JD; Adema K; Clapham PR
    J Virol; 1997 Sep; 71(9):6407-15. PubMed ID: 9261358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.
    Rawat SS; Viard M; Gallo SA; Blumenthal R; Puri A
    Glycoconj J; 2006 May; 23(3-4):189-97. PubMed ID: 16691502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thioredoxin-1 and protein disulfide isomerase catalyze the reduction of similar disulfides in HIV gp120.
    Reiser K; François KO; Schols D; Bergman T; Jörnvall H; Balzarini J; Karlsson A; Lundberg M
    Int J Biochem Cell Biol; 2012 Mar; 44(3):556-62. PubMed ID: 22230366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5.
    Davis CB; Dikic I; Unutmaz D; Hill CM; Arthos J; Siani MA; Thompson DA; Schlessinger J; Littman DR
    J Exp Med; 1997 Nov; 186(10):1793-8. PubMed ID: 9362541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
    Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
    Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques.
    Vödrös D; Thorstensson R; Doms RW; Fenyö EM; Reeves JD
    Virology; 2003 Nov; 316(1):17-28. PubMed ID: 14599787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.